Beyond BRCA Status: Clinical Biomarkers May Predict Therapeutic Effects of Olaparib in Platinum-Sensitive Ovarian Cancer Recurrence

The purpose of this study was to investigate the predictors of the effect of olaparib on platinum-sensitive recurrent ovarian cancer with unknown germline BRCA mutations. We retrospectively examined 20 patients with platinum-sensitive ovarian cancer who were treated at the Nippon Medical School Chib...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakanishi, Kazuho, Yamada, Takashi, Ishikawa, Gen, Suzuki, Shunji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358390/
https://www.ncbi.nlm.nih.gov/pubmed/34395265
http://dx.doi.org/10.3389/fonc.2021.697952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358390/
https://www.ncbi.nlm.nih.gov/pubmed/34395265
http://dx.doi.org/10.3389/fonc.2021.697952

Ejemplares similares